Navigation Links
Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets
Date:10/7/2010

is currently being evaluated in the BR.26 clinical trial, a Phase 3, double-blind, placebo-controlled, randomized study in patients with stage IIIB/IV NSCLC who have progressive disease following standard chemotherapy and EGFR inhibitor therapy.(3) BR.26 is led by the NCIC Clinical Trials Group (CTG).(3)

  • Crizotinib (PF-02341066)

Updated data on crizotinib (PF-02341066), a first-in-class, oral ALK inhibitor, will also be presented, from the ongoing expansion cohort from the Phase 1 study evaluating the compound in patients with ALK-positive advanced NSCLC (Abstract #366PD, October 10).(4)

  • Sunitinib

Pfizer will also present results from SUN 1087, a Phase 3 trial evaluating sunitinib plus erlotinib compared to erlotinib alone in patients with advanced NSCLC who have received at least one previous treatment with a platinum-based regimen (Abstract #LBA6, October 11).(5)  In August, Pfizer announced that this study demonstrated a statistically significant improvement in progression-free survival but not in overall survival.  Overall survival was the primary endpoint of the study and progression free survival was the secondary endpoint of the study.

Pfizer will also present progression-free survival (PFS) data as determined by blinded independent central review (BICR) from the pivotal, placebo-controlled SUN 1111 Phase 3 trial evaluating sunitinib in patients with progressive, well-differentiated pancreatic neuroendocrine tumor (NET) (Abstract #747P, October 9).(6)

  • Figitumumab

Results from a Phase 1/2 study evaluating figitumumab (CP-751,871), a selective fully human IgG2 monoclonal antibody against the IGF-1R (insulin-like growth factor 1 receptor) pathway, in patients with refractory Ewing's sarcoma and other sarcomas will be presented in a Proffe
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- SAM ... (Axilla) Strap for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today that ... recall to address a potential issue with a ... for the Axilla application of the SAM Junctional ...
(Date:8/29/2014)... , Aug. 29, 2014  A Boston ... multinational study on stent removability and preliminary long ... been published in the August issue of the ... study 1 is being conducted in 11 ... fully covered self-expanding metal stents (FCSEMS) after extended ...
(Date:8/29/2014)... 29, 2014 Medina Medical announced today that ... of the Board of Directors on August 18, 2014. ... and commercialization experience, including over a decade of direct ... as a Partner of the medical device incubator The ... two Foundry start-ups. Mr. Engelson previously served as the ...
Breaking Medicine Technology:SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... , ARDEE, Ireland, Dec. 11 As ... disclosed, its acquisition of the global branded prescription pharmaceuticals ... October 30, 2009 (the "PGP Acquisition"), constituted a change ... (the "Marketing Agreement") between a P&G subsidiary acquired by ...
... , BATESVILLE, Ind., Dec. 11 ... Hill-Rom,s Advanta(TM) 2 Bed for use in medical-surgical areas of hospitals and ... safety features and the flexibility to use a variety of care surfaces ... to our customers. It combines the best features of Hill-Rom,s long-time leader, ...
Cached Medicine Technology:Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 2Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 3Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 4Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 2Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 3Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 4
(Date:8/30/2014)... UWDress.com, a distinguished wedding dress supplier, has gained a great ... outfits. Recently, the company has unveiled its beautiful collection of ... offer, all these brand new products are provided with big ... excited to unveil the new and trendy bridesmaid outfits and ... available at low prices now. The purpose of our company ...
(Date:8/30/2014)... Recently, iFitDress.com, one of the most ... of classy bridesmaid dresses . For additional information, ... percent off to 62 percent off) for all people ... , True enough, iFitDress.com is an industry leader ... The company persists in making trendy products that can ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 The Truth about ... body that will reveal to users some shocking foods that ... great results in modeling looks, as well as some motivation ... method says that there is one unique trick that can ... indicates that despite what many people might think, cardio exercise ...
(Date:8/30/2014)... 2014 Fast hosting is a ... has recently compared many professional web hosting suppliers ... and Arvixe are the suppliers of fastest web ... find a good fast hosting supplier. Actually, these ... uptime, server speed and customer support. People can ...
(Date:8/30/2014)... 2014 According to Bloomberg , ... requires Takeda Pharmaceutical Co. and Eli Lilly & Co. ... that the drugmakers concealed information about a risk of ... case, Allen v. Takeda Pharmaceuticals North America Inc. (12-cv-00064), ... of Louisiana (Lafayette).* , According to Bloomberg, Takeda and ...
Breaking Medicine News(10 mins):Health News:UWDress.com’s Beautiful Collection Of “Flowy Bridesmaid Dresses” Released 2Health News:Classy Bridesmaid Dresses Announced By Loved Online Supplier iFitDress.com 2Health News:Truth about Six Pack Abs Review Reveals Unique Method to Eliminate Stubborn Stomach Fat 2Health News:Fastest Web Hosting Suppliers In 2014 Announced By Top10BestSEOHosting.com 2Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Decision to Uphold $9 Billion Actos Award 2
... Israel, Nov. 21 Shamir,Optical Industry Ltd. (Nasdaq: ... earnings results on Tuesday, November 27, 2007, and has,scheduled ... A.M. EST that,morning., The conference call will be ... go to http://www.kcsa.com approximately five minutes before,the ...
... 2007 Full-Year Financial Outlook, WOODCLIFF LAKE, N.J., Nov. ... today filed with the U.S.,Securities and Exchange Commission (SEC) ... 2007. The filing of Par,s Form 10-Qs for these ... restating its consolidated,financial statements for certain prior periods, which ...
... Open access online journal,AZoJono* (The AZo Journal ... research edition in conjunction with DESYGN-IT*, an ... investigating the design,synthesis, growth and application of ... URL for special edition,[ http://www.azonano.com/nanotechnology%20journal.asp ...
... 20 CHF,International has been selected as the ... Fund) new Principal Recipient (PR) for,HIV/AIDS prevention, treatment ... awarded an HIV proposal in Round 3 programming., ... years, CHF will be directly responsible for,managing Honduras, ...
... S.C., Nov. 20 BlueCross BlueShield of ... awarded Case Management,Accreditation from URAC, a Washington, ... standards for the health care,industry. URAC,s ... a process to assess, plan and implement ...
... 20 2007 Vase or face" When presented with the well ... the faces of two people, what we observe depends on the ... , In this example, whether you see faces or vases depends ... always stays exactly the same, said John Serences, a UC Irvine ...
Cached Medicine News:Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing Third Quarter 2007 Earnings Results 2Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 2Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 3Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 4Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 5Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 6Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 7Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 8Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 9Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 10Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 11Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 12Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 13Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 14Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 15Health News:Major EU Funded Nanotube Research Group, DESYGN-IT, Publish in AZoJono - The Open Access Online Nanotech Journal 2Health News:CHF International Named Global Fund Principal Recipient in Honduras 2Health News:S.C. BlueCross BlueShield Receives URAC Case Management Accreditation 2Health News:Scientists uncover how the brain controls what the eyes see 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: